Optimal use of lipid-altering therapy

Guidelines versus evidence

Research output: Contribution to journalReview article

Original languageEnglish
Pages (from-to)269-272
Number of pages4
JournalFuture Lipidology
Volume8
Issue number3
DOIs
StatePublished - Jun 2013

Fingerprint

Dyslipidemias
Hyperlipidemias
Coronary Disease
Atherosclerosis
Guidelines
Lipids
Therapeutics

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Optimal use of lipid-altering therapy : Guidelines versus evidence. / Hilleman, Daniel E.

In: Future Lipidology, Vol. 8, No. 3, 06.2013, p. 269-272.

Research output: Contribution to journalReview article

@article{048e7e84e3fe4b958cb378c20bd19edf,
title = "Optimal use of lipid-altering therapy: Guidelines versus evidence",
author = "Hilleman, {Daniel E.}",
year = "2013",
month = "6",
doi = "10.2217/clp.13.18",
language = "English",
volume = "8",
pages = "269--272",
journal = "Clinical Lipidology",
issn = "1746-0875",
publisher = "Future Medicine Ltd.",
number = "3",

}

TY - JOUR

T1 - Optimal use of lipid-altering therapy

T2 - Guidelines versus evidence

AU - Hilleman, Daniel E.

PY - 2013/6

Y1 - 2013/6

UR - http://www.scopus.com/inward/record.url?scp=84878676511&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878676511&partnerID=8YFLogxK

U2 - 10.2217/clp.13.18

DO - 10.2217/clp.13.18

M3 - Review article

VL - 8

SP - 269

EP - 272

JO - Clinical Lipidology

JF - Clinical Lipidology

SN - 1746-0875

IS - 3

ER -